Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

As school returns, so do infections & asthma emergencies. Where kids live can make it worse

Written by | 18 Aug 2025

Asthma-related emergency room visits spike every year when kids return to school and are exposed to respiratory viruses like common colds and the flu — and the increase… read more.

Positive topline results from landmark ASPEN study of brensocatib in patients with bronchiectasis – Insmed

Written by | 16 Aug 2025

Insmed announced positive topline results from the ASPEN study, a global, randomized, double-blind, placebo-controlled Phase III study to assess the efficacy, safety, and tolerability of brensocatib in patients… read more.

Trixeo Aerosphere approved in the UK as first inhaled respiratory medicine using next-generation propellant with near-zero Global Warming Potential – AstraZeneca

Written by | 14 Aug 2025

AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF), already licensed for the treatment of chronic obstructive pulmonary disease (COPD) in adults, has now been approved for use in the… read more.

Air purifiers may reduce heart risks for people exposed to traffic pollution

Written by | 12 Aug 2025

Using portable high-efficiency particulate air (HEPA) purifiers at home can significantly lower systolic blood pressure (SBP) in adults with elevated baseline readings — even in areas with relatively low… read more.

Study reveals hidden drivers of asthma flare-ups in children

Written by | 6 Aug 2025

A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics. Eosinophilic asthma is characterized… read more.

Asthma: patient expectations influence the course of the disease

Written by | 13 Jul 2025

Individual expectations about one’s health can influence him/her future condition and the speed of the progression of a disease: in fact, a research conducted by researchers of psychology… read more.

Vaping exposes pregnant women to fewer toxins than smoking

Written by | 3 Jul 2025

Pregnant women are exposed to lower levels of toxic chemicals if they vape during pregnancy compared with if they smoke cigarettes, according to new research led by scientists… read more.

Women who work nightshifts are more likely to have asthma

Written by | 21 Jun 2025

Women who work night shifts are more likely to suffer with moderate or severe asthma compared to women who work in the daytime, according to a study published… read more.

BATURA Phase III trial results provide new evidence for Airsupra as standard of care for as-needed rescue treatment in asthma – AstraZeneca

Written by | 4 Jun 2025

Positive full results from the BATURA Phase IIIb trial showed AstraZeneca’s anti-inflammatory reliever rescue therapy, Airsupra (albuterol/budesonide), demonstrated statistically significant and clinically meaningful improvements in all primary and… read more.

Standardising disposable vape devices may curb young people’s desire to try them

Written by | 1 Jun 2025

Standardising the colour and branding of disposable vaping devices may deter young people who have never smoked or vaped from trying them in the first place, suggests a… read more.

ED visits for asthma spiked during 2023 Canadian wildfires

Written by | 27 May 2025

New research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241506 found an increase in asthma-related emergency department (ED) visits across Ontario following heavy smoke in early June 2023. Canada experienced the most destructive wildfire… read more.

New data for Airsupra and Breztri highlight progress in advancing asthma and COPD care globally

Written by | 16 May 2025

AstraZeneca will present the latest clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International Conference, in… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.